Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells (Q43773214)

26 November 2017

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells (English)

1 reference

26 November 2017

Clay CE

1

1 reference

26 November 2017

Atsumi GI

series ordinal

2

1 reference

26 November 2017

High KP

series ordinal

3

1 reference

26 November 2017

Chilton FH

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of Biological Chemistry

26 November 2017

1 reference

26 November 2017

276

1 reference

26 November 2017

50

1 reference

26 November 2017

47131-47135

1 reference

15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells

26 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Comparative study of the effects of polyunsaturated fatty acids and their metabolites on cell growth and tyrosine kinase activity in oesophageal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

The nature and composition of 15-deoxy-Delta(12,14)PGJ(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

The maturation of nucleic acid technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Prognostic role of p27Kip1 and apoptosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Relationship between arachidonate--phospholipid remodeling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Intracellular unesterified arachidonic acid signals apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100339200

21 January 2018

Identifiers

DOI

10.1074/JBC.C100339200

1 reference

26 November 2017

1 reference